ArticleOncotarget2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Sarah Kammerer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncotarget2016
Sarah Kammerer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.